Cambridge trial to explore effects of hormone on frontotemporal dementia

Researchers in Cambridge are embarking on a pilot trial to investigate the potential of the hormone oxytocin to combat early symptoms of frontotemporal dementia (FTD), backed by a grant from Alzheimer’s Research UK.